Arcadia CFO Mark Kawakami resigns; CEO Schaefer adds interim CFO role

Arcadia Biosciences, Inc.

CFO Mark Kawakami resigns effective September 12, 2025; not due to any disagreement with the Company or auditors.
CEO Thomas J. Schaefer appointed interim CFO and principal accounting officer, effective upon Kawakami's resignation.
Schaefer previously served as CFO from January 2023 to July 2024; no compensation change for the additional role.
Schaefer will be available as an advisor after his departure; transition proceeds smoothly.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.